<- Go Home
Ypsomed Holding AG
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication in Switzerland, Europe, North America, and internationally. The company offers various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other related services. It offers contract manufacturing of infusion sets and reservoirs. The company markets its products to hospitals, doctors, pharmacies and patients via subsidiaries and distributors. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.
Market Cap
CHF 4.5B
Volume
17.8K
Cash and Equivalents
CHF 28.6M
EBITDA
CHF 328.3M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
CHF 314.6M
Profit Margin
43.04%
52 Week High
CHF 441.50
52 Week Low
CHF 260.50
Dividend
N/A
Price / Book Value
6.04
Price / Earnings
20.42
Price / Tangible Book Value
7.25
Enterprise Value
CHF 4.7B
Enterprise Value / EBITDA
14.20
Operating Income
CHF 246.1M
Return on Equity
31.09%
Return on Assets
11.49
Cash and Short Term Investments
CHF 28.6M
Debt
CHF 149.0M
Equity
CHF 748.1M
Revenue
CHF 731.0M
Unlevered FCF
-CHF 66.9M
Sector
Health Care Equipment and Supplies
Category
N/A